In conclusion, we propose that long-lasting Th17 responses may precede the onset of gastric cancer and suggest that measurement of IL-17 family cytokines might be useful not only for the management of AIG but also for predicting the development of gastric cancer in AIG patients with gastric atrophy. The gene discussed is IL17A; the disease is chronic atrophic gastritis.